Global Initiative for Chronic Obstructive Lung Disease

from Wikipedia, the free encyclopedia

The Global Initiative for Chronic Obstructive Lung Disease ( GOLD ), German: Global Initiative for Chronic Obstructive Lung Diseases , was launched in 1997 by the World Health Organization ( WHO ) and the National Institute of Health ( NIH ) in order to optimize the diagnosis process worldwide To implement treatment and prevention of the largely unknown widespread disease COPD .

The GOLD aims to

  1. To recommend globally valid strategies for dealing with COPD and its avoidance
  2. Draw the attention of the medical community , health policymakers and the general public to the fact that COPD is a health problem of general concern
  3. Reduce the incidence and mortality of this disease by deploying and evaluating effective programs to diagnose and treat COPD
  4. Promote a scientific debate to answer the question of why COPD is on the rise, including the relationship to environmental factors
  5. effective programs to avoid: and ultimately COPD set

GOLD is financially supported by several large pharmaceutical companies from America, Europe and Japan.

See also: bronchial asthma , emphysema

Web links